DRAMAMINE — N- meclizine hydrochloride tablet
Medtech Products Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Meclizine HCl 25 mg
for prevention and treatment of these symptoms associated with motion sickness:
■nausea ■vomiting ■dizziness
for children under 12 years of age unless directed by a doctor
■ a breathing problem such as emphysema or chronic bronchitis
■ trouble urinating due to an enlarged prostate gland
sedatives or tranquilizers
■ drowsiness may occur
■ avoid alcoholic drinks
■ alcohol, sedatives, and tranquilizers may increase drowsiness
■ be careful when driving a motor vehicle or operating machinery
ask a doctor before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
■ take first dose one hour before activity that may result in nausea
■ adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor
■ store at room temperature 20°–25°C (68°-77°F)
anhydrous lactose, corn starch, colloidal silicon dioxide, D&C yellow no. 10 aluminum lake, magnesium stearate, microcrystalline cellulose
Meclizine Hydrochloride Tablets/Antiemetic
| DRAMAMINE — N |
meclizine hydrochloride tablet
|Labeler — Medtech Products Inc. (122715688)|
Revised: 02/2019 Medtech Products Inc.
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.